Medication info

Glucear Extended Release Tablet 500mg (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
White rectangular tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201400115 · Approved 2014.01.13

Summary

Main use
Treatment of type 2 diabetes mellitus in adults
Who takes it
Adults
Adult dose
The dose should be determined individually based on the efficacy and tolerability of the medicine, and should not exceed the recommended maximum daily dose. - The usual initial dose is metformin hydrochloride extended-release tablets 500mg once daily with the evening meal. - Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week, up to a maximum of 2000mg per day with the evening meal. If glycemic control is not achieved with a maximum once-daily dose of 2000mg, consider administering 1000mg twice daily, with both doses taken with meals. - In patients already treated with metformin tablets, the initial dose of this formulation is the same as the daily dose of immediate-release metformin tablets. Switching to this formulation is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to treatment with this medicine and determine the minimum effective dose. Measure glycated hemoglobin levels approximately every 3 months. - The goal of treatment with this medicine, when given as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be closely monitored every 3- 6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73m2, respectively, this medicine must be discontinued immediately.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus in adults

  • Type 2 diabetes with insufficient blood sugar control
View approved original text

This medication is used for patients with type 2 diabetes who have difficulty controlling their blood sugar levels with diet and exercise alone, especially if they are overweight. It can be used alone or in combination with other oral hypoglycemic agents or insulin, effectively controlling blood sugar levels. This medication helps manage blood sugar within the normal range, improving diabetes symptoms and contributing to the prevention of complications.

How to take

Adult dose

The dose should be determined individually based on the efficacy and tolerability of the medicine, and should not exceed the recommended maximum daily dose. - The usual initial dose is metformin hydrochloride extended-release tablets 500mg once daily with the evening meal. - Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week, up to a maximum of 2000mg per day with the evening meal. If glycemic control is not achieved with a maximum once-daily dose of 2000mg, consider administering 1000mg twice daily, with both doses taken with meals. - In patients already treated with metformin tablets, the initial dose of this formulation is the same as the daily dose of immediate-release metformin tablets. Switching to this formulation is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to treatment with this medicine and determine the minimum effective dose. Measure glycated hemoglobin levels approximately every 3 months. - The goal of treatment with this medicine, when given as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be closely monitored every 3- 6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73m2, respectively, this medicine must be discontinued immediately.

Precautions

This medication can rarely cause a serious condition called lactic acidosis. Lactic acidosis is a condition where the concentration of lactate in the blood becomes abnormally high, leading to harmful effects on the body, which can be life-threatening if not treated. Caution is necessary when using this medication with insulin or other diabetes treatments, as hypoglycemia can occur. Hypoglycemia can result in low blood sugar levels leading to dizziness, cold sweat, and even loss of consciousness. This medication should not be used in patients with moderate to severe renal impairment, dehydration, serious infections, or acute illnesses that can affect renal function, such as acute myocardial infarction. In specific patient groups, such as those with acute or unstable heart failure, those due to undergo tests with iodinated contrast agents, patients allergic to this medication's components, and type 1 diabetes patients, use of this medication is contraindicated. In the case of surgery, especially before and after surgery when food and fluid intake is restricted, this medication should be temporarily discontinued and resumed only after confirming normal kidney function. This medication may cause gastrointestinal disturbances, particularly during the initial phase of treatment, where nausea, vomiting, and diarrhea are common. These symptoms usually resolve over time, but if severe, consulting a physician is necessary. Regular renal function tests should be performed to ensure this medication does not accumulate in the body, and especially in the elderly or patients with slightly impaired renal function, more frequent testing is required. Alcohol may increase the risk of lactic acidosis, a side effect of this medication, so excessive drinking should be avoided while taking it. Vitamin B12 deficiency may occur; therefore, regular blood tests are recommended to monitor this. During pregnancy, this medication may cross the placenta to the fetus; thus, patients who are planning to become pregnant or are pregnant should consult a doctor before use. This medication is not recommended for children under 17 years of age, and dosage adjustments should be made for the elderly based on kidney function. In case of overdose, this medication can be removed through dialysis; therefore, if overdose is suspected, immediate medical attention should be sought. This medication may interact with other drugs; therefore, patients should inform their doctor or pharmacist of any other medications they are taking. This medication should be swallowed whole without chewing or crushing, and it is normal for the tablet coating to be excreted in the stool. Regular blood sugar testing and renal function monitoring should be performed during medication use to continuously check for treatment effectiveness and side effects.

Side effects

  • Lactic acidosis
  • severe hypoglycemia
  • vitamin B12 deficiency
  • taste disturbance
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • erythema
Show 3 more
  • itching
  • urticaria
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly closed container. The recommended storage temperature is room temperature between 1 and 30 degrees. Proper storage can maintain the medication's effectiveness for an extended period.

Appearance and packaging

Appearance

White rectangular tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.